Skip to main content
Erschienen in: Journal of Neural Transmission 11/2011

01.11.2011 | Dementias - Original Article

Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID)

verfasst von: Richard A. Armstrong, Marla Gearing, Eileen H. Bigio, Felix F. Cruz-Sanchez, Charles Duyckaerts, Ian R. A. Mackenzie, Robert H. Perry, Kari Skullerud, Hideaki Yokoo, Nigel J. Cairns

Erschienen in: Journal of Neural Transmission | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Neuronal intermediate filament inclusion disease (NIFID), a rare form of frontotemporal lobar degeneration (FTLD), is characterized neuropathologically by focal atrophy of the frontal and temporal lobes, neuronal loss, gliosis, and neuronal cytoplasmic inclusions (NCI) containing epitopes of ubiquitin and neuronal intermediate filament (IF) proteins. Recently, the ‘fused in sarcoma’ (FUS) protein (encoded by the FUS gene) has been shown to be a component of the inclusions of NIFID. To further characterize FUS proteinopathy in NIFID, we studied the spatial patterns of the FUS-immunoreactive NCI in frontal and temporal cortex of 10 cases. In the cerebral cortex, sectors CA1/2 of the hippocampus, and the dentate gyrus (DG), the FUS-immunoreactive NCI were frequently clustered and the clusters were regularly distributed parallel to the tissue boundary. In a proportion of cortical gyri, cluster size of the NCI approximated to those of the columns of cells was associated with the cortico-cortical projections. There were no significant differences in the frequency of different types of spatial patterns with disease duration or disease stage. Clusters of NCI in the upper and lower cortex were significantly larger using FUS compared with phosphorylated, neurofilament heavy polypeptide (NEFH) or α-internexin (INA) immunohistochemistry (IHC). We concluded: (1) FUS-immunoreactive NCI exhibit similar spatial patterns to analogous inclusions in the tauopathies and synucleinopathies, (2) clusters of FUS-immunoreactive NCI are larger than those revealed by NEFH or ΙΝΑ, and (3) the spatial patterns of the FUS-immunoreactive NCI suggest the degeneration of the cortico-cortical projections in NIFID.
Literatur
Zurück zum Zitat Armstrong RA (1993a) Is the clustering of neurofibrillary tangles in Alzheimer’s patients related to the cells of origin of specific cortico-cortical projections? Neurosci Lett 160:57–60PubMedCrossRef Armstrong RA (1993a) Is the clustering of neurofibrillary tangles in Alzheimer’s patients related to the cells of origin of specific cortico-cortical projections? Neurosci Lett 160:57–60PubMedCrossRef
Zurück zum Zitat Armstrong RA (1993b) The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders, with particular reference to plaque formation in Alzheimer’s disease. Neurodegeneration 2:73–80 Armstrong RA (1993b) The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders, with particular reference to plaque formation in Alzheimer’s disease. Neurodegeneration 2:73–80
Zurück zum Zitat Armstrong RA (1997) Analysis of spatial patterns in histological sections of brain tissue. J Neurosci Meth 73:141–147CrossRef Armstrong RA (1997) Analysis of spatial patterns in histological sections of brain tissue. J Neurosci Meth 73:141–147CrossRef
Zurück zum Zitat Armstrong RA (2006) Methods of studying the planar distribution of objects in histological sections of brain tissue. J Microsc 221:153–158PubMedCrossRef Armstrong RA (2006) Methods of studying the planar distribution of objects in histological sections of brain tissue. J Microsc 221:153–158PubMedCrossRef
Zurück zum Zitat Armstrong RA, Cairns NJ (2006a) Topography of α-internexin-positive neuronal aggregates in 10 patients with neuronal intermediate filament inclusion disease. Eur J Neurol 13:528–532PubMedCrossRef Armstrong RA, Cairns NJ (2006a) Topography of α-internexin-positive neuronal aggregates in 10 patients with neuronal intermediate filament inclusion disease. Eur J Neurol 13:528–532PubMedCrossRef
Zurück zum Zitat Armstrong RA, Cairns NJ (2006b) Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID). A study using α-internexin immunohistochemistry. Clin Neuropathol 25:209–215PubMed Armstrong RA, Cairns NJ (2006b) Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID). A study using α-internexin immunohistochemistry. Clin Neuropathol 25:209–215PubMed
Zurück zum Zitat Armstrong RA, Cairns NJ (2007) Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID), an α-internexin immunohistochemical study. J Neural Transm 114:451–456PubMedCrossRef Armstrong RA, Cairns NJ (2007) Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID), an α-internexin immunohistochemical study. J Neural Transm 114:451–456PubMedCrossRef
Zurück zum Zitat Armstrong RA, Cairns NJ, Lantos PL (1997) Dementia with Lewy bodies: clustering of Lewy bodies in human patients. Neurosci Lett 224:41–44PubMedCrossRef Armstrong RA, Cairns NJ, Lantos PL (1997) Dementia with Lewy bodies: clustering of Lewy bodies in human patients. Neurosci Lett 224:41–44PubMedCrossRef
Zurück zum Zitat Armstrong RA, Cairns NJ, Lantos PL (1998) Clustering of pick bodies in pick’s disease. Neurosci Lett 242:81–84PubMedCrossRef Armstrong RA, Cairns NJ, Lantos PL (1998) Clustering of pick bodies in pick’s disease. Neurosci Lett 242:81–84PubMedCrossRef
Zurück zum Zitat Armstrong RA, Cairns NJ, Lantos PL (1999) Clustering of cerebral cortical lesions in patients with corticobasal degeneration. Neurosci Lett 268:5–8PubMedCrossRef Armstrong RA, Cairns NJ, Lantos PL (1999) Clustering of cerebral cortical lesions in patients with corticobasal degeneration. Neurosci Lett 268:5–8PubMedCrossRef
Zurück zum Zitat Armstrong RA, Cairns NJ, Lantos PL (2001) What does the study of spatial patterns tell us about the pathogenesis of neurodegenerative disorders? Neuropathology 21:1–12PubMedCrossRef Armstrong RA, Cairns NJ, Lantos PL (2001) What does the study of spatial patterns tell us about the pathogenesis of neurodegenerative disorders? Neuropathology 21:1–12PubMedCrossRef
Zurück zum Zitat Armstrong RA, Lantos PL, Cairns NJ (2004) Spatial patterns of α-synuclein positive glial cytoplasmic inclusions in multiple system atrophy. Move Disord 19:109–112CrossRef Armstrong RA, Lantos PL, Cairns NJ (2004) Spatial patterns of α-synuclein positive glial cytoplasmic inclusions in multiple system atrophy. Move Disord 19:109–112CrossRef
Zurück zum Zitat Armstrong RA, Kerty E, Skullerud K, Cairns NJ (2006) Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using α-internexin immunohistochemistry and principal components analysis (PCA). J Neural Transm 113:1207–1215PubMedCrossRef Armstrong RA, Kerty E, Skullerud K, Cairns NJ (2006) Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using α-internexin immunohistochemistry and principal components analysis (PCA). J Neural Transm 113:1207–1215PubMedCrossRef
Zurück zum Zitat Armstrong RA, Lantos PL, Cairns NJ (2007) Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinson Rel Disord 13:50–54CrossRef Armstrong RA, Lantos PL, Cairns NJ (2007) Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinson Rel Disord 13:50–54CrossRef
Zurück zum Zitat Armstrong RA, Ellis W, Hamilton RL, Mackenzie IRA, Hedreen J, Gearing M, Montine T, Vonsattel J-P, Head E, Lieberman AP, Cairns NJ (2010) Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm 117:227–239PubMedCrossRef Armstrong RA, Ellis W, Hamilton RL, Mackenzie IRA, Hedreen J, Gearing M, Montine T, Vonsattel J-P, Head E, Lieberman AP, Cairns NJ (2010) Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm 117:227–239PubMedCrossRef
Zurück zum Zitat Bigio EH, Lipton AM, White CL, Dickson DW, Hirano A (2003) Frontotemporal dementia and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 29:239–253PubMedCrossRef Bigio EH, Lipton AM, White CL, Dickson DW, Hirano A (2003) Frontotemporal dementia and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 29:239–253PubMedCrossRef
Zurück zum Zitat Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM (2003) Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60:1005–1011PubMed Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM (2003) Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60:1005–1011PubMed
Zurück zum Zitat Cairns NJ, Armstrong RA (2003) Clustering of neuronal inclusions in “dementia with neurofilament inclusions”. Acta Neuropathol 106:125–128PubMedCrossRef Cairns NJ, Armstrong RA (2003) Clustering of neuronal inclusions in “dementia with neurofilament inclusions”. Acta Neuropathol 106:125–128PubMedCrossRef
Zurück zum Zitat Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL (2003) Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 341:177–180PubMedCrossRef Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL (2003) Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 341:177–180PubMedCrossRef
Zurück zum Zitat Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VMY, Trojanowski JQ (2004a) α-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 164:2153–2161PubMedCrossRef Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VMY, Trojanowski JQ (2004a) α-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 164:2153–2161PubMedCrossRef
Zurück zum Zitat Cairns NJ, Jaros E, Perry RH, Armstrong RA (2004b) Temporal lobe pathology of human patients with neurofilament inclusion disease. Neurosci Lett 354:245–247PubMedCrossRef Cairns NJ, Jaros E, Perry RH, Armstrong RA (2004b) Temporal lobe pathology of human patients with neurofilament inclusion disease. Neurosci Lett 354:245–247PubMedCrossRef
Zurück zum Zitat Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM-Y, Trojanowski JQ (2004c) Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID). Neurology 63:1376–1384PubMed Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM-Y, Trojanowski JQ (2004c) Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID). Neurology 63:1376–1384PubMed
Zurück zum Zitat Ching GY, Liein RKH (1998) Roles of head and tail domains in alpha-internexin’s self-assembly and coassembly with the neurofilament triplet proteins. J Cell Sci 111:321–333PubMed Ching GY, Liein RKH (1998) Roles of head and tail domains in alpha-internexin’s self-assembly and coassembly with the neurofilament triplet proteins. J Cell Sci 111:321–333PubMed
Zurück zum Zitat Ching GY, Chien CL, Flores R, Liein RKH (1999) Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J Neurosci 19:2974–2986PubMed Ching GY, Chien CL, Flores R, Liein RKH (1999) Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J Neurosci 19:2974–2986PubMed
Zurück zum Zitat De Lacoste M, White CL III (1993) The role of cortical connectivity in Alzheimer’s disease pathogenesis: a review and model system. Neurobiol Aging 14:1–16PubMedCrossRef De Lacoste M, White CL III (1993) The role of cortical connectivity in Alzheimer’s disease pathogenesis: a review and model system. Neurobiol Aging 14:1–16PubMedCrossRef
Zurück zum Zitat Delatour B, Blanchard V, Pradier L, Duyckaerts C (2004) Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiol Dis 16:41–47PubMedCrossRef Delatour B, Blanchard V, Pradier L, Duyckaerts C (2004) Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiol Dis 16:41–47PubMedCrossRef
Zurück zum Zitat Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317–325PubMedCrossRef Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317–325PubMedCrossRef
Zurück zum Zitat Hiorns RW, Neal JW, Pearson RCA, Powell TPS (1991) Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc Roy Soc (Lond) 246:1–9CrossRef Hiorns RW, Neal JW, Pearson RCA, Powell TPS (1991) Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc Roy Soc (Lond) 246:1–9CrossRef
Zurück zum Zitat Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T (2003) Neurofilament inclusion body disease: a new proteinopathy? Brain 126:2291–2303PubMedCrossRef Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T (2003) Neurofilament inclusion body disease: a new proteinopathy? Brain 126:2291–2303PubMedCrossRef
Zurück zum Zitat Kwiatkowski TJ, Bosco DA, LeClerc AL, Tamrajian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hisler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Hainer JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddigne T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208PubMedCrossRef Kwiatkowski TJ, Bosco DA, LeClerc AL, Tamrajian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hisler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Hainer JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddigne T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208PubMedCrossRef
Zurück zum Zitat Munoz DG, Neumann M, Kusaka H, Yokata O, Ishihara K, Terada S, Kuroda S, Mackenzie IR (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118:617–627PubMedCrossRef Munoz DG, Neumann M, Kusaka H, Yokata O, Ishihara K, Terada S, Kuroda S, Mackenzie IR (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118:617–627PubMedCrossRef
Zurück zum Zitat Neumann M, Roeher S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IRA (2009a) Abundant FUS-immunoreactive pathology in Neuronal intermediate filament inclusion disease (NIFID). Acta Neuropathol 118:605–616PubMedCrossRef Neumann M, Roeher S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IRA (2009a) Abundant FUS-immunoreactive pathology in Neuronal intermediate filament inclusion disease (NIFID). Acta Neuropathol 118:605–616PubMedCrossRef
Zurück zum Zitat Neumann M, Eademakers R, Roeher S, Baker M, Kretzschmar HA, Mackenzie IRA (2009b) A new type of frontotemporal lobar degeneration with FUS pathology. Brain 132:2922–2931PubMedCrossRef Neumann M, Eademakers R, Roeher S, Baker M, Kretzschmar HA, Mackenzie IRA (2009b) A new type of frontotemporal lobar degeneration with FUS pathology. Brain 132:2922–2931PubMedCrossRef
Zurück zum Zitat Valdmanis PN, Daoud H, Dion PA, Rouleau GA (2009) Recent advances in the genetics of amyotrophic lateral sclerosis. Current Neurol Neurosci Rep 9:198–205CrossRef Valdmanis PN, Daoud H, Dion PA, Rouleau GA (2009) Recent advances in the genetics of amyotrophic lateral sclerosis. Current Neurol Neurosci Rep 9:198–205CrossRef
Zurück zum Zitat Vance C, Rogelj B, Hortobagyi T, de Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Gariesalingam J, Williams KL, tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE (2009) Mutations in FUS an RNA processing protein cause familial amyotrophic lateral sclerosis Type 6. Science 323:1208–1211PubMedCrossRef Vance C, Rogelj B, Hortobagyi T, de Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Gariesalingam J, Williams KL, tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE (2009) Mutations in FUS an RNA processing protein cause familial amyotrophic lateral sclerosis Type 6. Science 323:1208–1211PubMedCrossRef
Metadaten
Titel
Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID)
verfasst von
Richard A. Armstrong
Marla Gearing
Eileen H. Bigio
Felix F. Cruz-Sanchez
Charles Duyckaerts
Ian R. A. Mackenzie
Robert H. Perry
Kari Skullerud
Hideaki Yokoo
Nigel J. Cairns
Publikationsdatum
01.11.2011
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 11/2011
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-011-0690-x

Weitere Artikel der Ausgabe 11/2011

Journal of Neural Transmission 11/2011 Zur Ausgabe

Basic Neurosciences, Genetics and Immunology - Original Article

Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats

Basic Neurosciences, Genetics and Immunology - Original Article

Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.